Bristol-Myers Squibb sets $250 Million Devens Expansion

Source: PharmaManufacturing.com

Apr 16, 2013

The Boston Globe

Bristol-Myers Squibb Co., the global biopharmaceutical company, said Thursday that it will launch a $250 million expansion of its manufacturing complex in Devens and nearly double the size of its workforce there.
The expansion will add space for developing biotechnology drugs, called biologics, and for manufacturing those products for clinical trials, a requirement of the drug approval process. Read the full story.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments